Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Agomelatine SPC

The Summary of Product Characteristics for agomelatine (Valdoxan®) is now available via the electronic Medicines Compendium (eMC).

As previously discussed, agomelatine is a new class of antidepressant. The SPC gives more details for this drug including known side effects, precautions and interactions.

Action: Clinicians who are considering using this new drug would be wise to review the SPC before starting a treatment.

Share 'Agomelatine SPC' on Email Share 'Agomelatine SPC' on Delicious Share 'Agomelatine SPC' on Digg Share 'Agomelatine SPC' on Facebook Share 'Agomelatine SPC' on Google+ Share 'Agomelatine SPC' on reddit Share 'Agomelatine SPC' on StumbleUpon Share 'Agomelatine SPC' on Twitter

atomic-wealth

No Comments to “Agomelatine SPC”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.

atomic-wealth
fond-illness
summer